ROCHE I/ CH0012032113 /
2024-03-28 1:36:02 PM | Chg. +1.00 | Volume | Bid1:37:56 PM | Ask1:37:56 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
241.00CHF | +0.42% | 15,555 Turnover: 3.75 mill. |
240.80Bid Size: 214 | 241.20Ask Size: 233 | 210.63 bill.CHF | 3.94% | 16.74 |
GlobeNewswire
12:05 PM
Xilio Therapeutics Announces $11.3 Million Private Placement Equity Financing
GlobeNewswire
12:00 PM
Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program
GlobeNewswire
03-22
HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highl...
GlobeNewswire
03-14
Monte Rosa Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides C...
GlobeNewswire
03-07
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Repare Therapeut...
GlobeNewswire
02-28
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Repare Therapeut...
GlobeNewswire
02-26
Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Ro...
GlobeNewswire
02-21
REPARE ALERT: Bragar Eagel & Squire, P.C. is Investigating Repare Therapeutics Inc. on Behalf of Rep...
GlobeNewswire
02-20
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Repare Therapeut...
GlobeNewswire
02-13
Roivant Reports Financial Results for the Third Quarter Ended December 31, 2023, and Provides Busine...
GlobeNewswire
01-30
COUR Pharmaceuticals Secures $105 Million in Series A Financing Co-Led by Lumira Ventures and Alpha ...
GlobeNewswire
01-03
US Neurologists Optimistic Regarding the Huntington’s Disease Treatment Pipeline, Emphasizing Haltin...
GlobeNewswire
01-03
Arch Biopartners Receives Approval from the Turkish Ministry of Health to Proceed with Phase II Tria...
GlobeNewswire
2023-12-29
LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche
GlobeNewswire
2023-12-14
Roche Completes Acquisition of Telavant from Roivant, Including Rights to Novel TL1A Directed Antibo...
GlobeNewswire
2023-12-13
U.S. Neurologists Eagerly Await Promising Oral Bruton’s Tyrosine Kinase Inhibitors in Multiple Scler...
GlobeNewswire
2023-11-30
ShapeTX Expands Strategic Collaboration with Roche with Addition of a New Target